{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:25:39Z","timestamp":1784046339006,"version":"3.55.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Ketogenic diet therapies (KDT) are high-fat, low carbohydrate diets used as an effective treatment option for drug-resistant epilepsy. There is limited research on the efficacy of KDT for super-refractory status epilepticus (SRSE). We systematically review evidence for use of KDT in children with SRSE and present a single UK tertiary centre's experience. Thirty one articles were included, of which 24 were \u201cmedium\u201d or \u201clow\u201d quality. One hundred and forty seven children with SRSE started KDT, of which 141 (96%) achieved ketosis. KDT was started mean 5.3 days (range 1\u2013420) after status epilepticus (SE) started. SRSE resolved in 85\/141 (60%) children after mean 6.3 days (range 0\u201319) post SE onset, but it is unclear whether further treatments were initiated post-KDT. 13\/141 (9%) children died. Response to KDT was more likely when initiated earlier (<jats:italic>p<\/jats:italic> = 0.03) and in females (<jats:italic>p<\/jats:italic> = 0.01). Adverse side effects were reported in 48\/141 (34%), mostly gastrointestinal; potentially serious adverse effects occurred in \u22644%. Eight children with SRSE, all diagnosed with febrile infection-related epilepsy syndrome, were treated with KDT at Great Ormond Street Hospital for Children. KDT was initiated enterally at mean day 13.6+\/\u2212 5.1 of admission. Seven of 8 (88%) children reported adverse side effects, which were potentially serious in 4\/8 (50%), including metabolic acidosis, hypoglycaemia and raised amylase. SE ceased in 6\/8 (75%) children after mean 25+\/\u2212 9.4 days post onset, but other treatments were often started concomitantly and all children started other treatments post-KDT. Two of 8 (25%) children died during admission and another died post-admission. Four of the remaining 5 children continue to have drug-resistant seizures, one of whom remains on KDT; seizure burden was unknown for one child. Our findings indicate that KDT is possible and safe in children with SRSE. Cessation of SRSE may occur in almost two-thirds of children initiated with KDT, but a causal effect is difficult to determine due to concomitant treatments, treatments started post-KDT and the variable length of time post-KDT onset when SRSE cessation occurs. Given that serious adverse side effects seem rare and response rates are (cautiously) favorable, KDT should be considered as an early treatment option in this group.<\/jats:p>","DOI":"10.3389\/fneur.2021.643105","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T06:13:41Z","timestamp":1615529621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Dietary Management of Children With Super-Refractory Status Epilepticus: A Systematic Review and Experience in a Single UK Tertiary Centre"],"prefix":"10.3389","volume":"12","author":[{"given":"Natasha E.","family":"Schoeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Eltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"CD001903","DOI":"10.1002\/14651858.CD001903.pub5","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain."},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/WNP.0000000000000223","article-title":"Is favorable outcome possible after prolonged refractory status epilepticus?","volume":"33","author":"Alvarez","year":"2016","journal-title":"J Clin Neurophysiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e12720","DOI":"10.1111\/ecc.12720","article-title":"Seeking, accepting and declining help for emotional distress in cancer: a systematic review and thematic synthesis of qualitative evidence","volume":"27","author":"Carolan","year":"2018","journal-title":"Eur J Cancer Care (Engl)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpm.12698","article-title":"Informal carer experiences of UK dementia services - A systematic review","author":"Francis","year":"2020","journal-title":"J Psychiatr Ment Health Nurs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2006.01.002","article-title":"Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis","volume":"69","author":"Mikaeloff","year":"2006","journal-title":"Epilepsy Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1111\/j.1528-1167.2011.03289.x","article-title":"The role of ketogenic diet in the treatment of refractory status epilepticus","volume":"52","author":"Nam","year":"2011","journal-title":"Epilepsia."},{"key":"B9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.braindev.2018.12.007","article-title":"The ketogenic diet for super-refractory status epilepticus patients in intensive care units","volume":"41","author":"Park","year":"2019","journal-title":"Brain Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer","year":"2011","journal-title":"Epilepsia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ncn3.12385","article-title":"Extinguishing FIRES using tocilizumab","volume":"8","author":"Chee","year":"2020","journal-title":"Neurol Clin Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0883073819872579","article-title":"Childhood small vessel primary angiitis of the central nervous system: a treatable cause of super-refractory status epilepticus","volume":"35","author":"Chiu","year":"2020","journal-title":"J Child Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"103970","DOI":"10.1016\/j.ejmg.2020.103970","article-title":"Rare homozygous nonsense variant in AIMP1 causing early onset epileptic encephalopathy with burst suppression (EOEE-BS)","volume":"63","author":"Gupta","year":"2020","journal-title":"Eur J Med Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42494-020-00013-1","article-title":"The ketogenic diet for paediatric patients with super-refractory status epilepticus in febrile infection-related epilepsy syndrome","volume":"2","author":"Wang","year":"2020","journal-title":"Acta Epileptologica."},{"key":"B15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/epi4.12317","article-title":"Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome","volume":"4","author":"Dilena","year":"2019","journal-title":"Epilepsia Open."},{"key":"B16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fneur.2019.00423","article-title":"Ketogenic diet as a treatment for super-refractory status epilepticus in febrile infection-related epilepsy syndrome","volume":"10","author":"Peng","year":"2019","journal-title":"Front Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yebeh.2019.02.033","article-title":"The short-term and long-term outcome of febrile infection-related epilepsy syndrome in children","volume":"95","author":"Lam","year":"2019","journal-title":"Epilepsy Behav."},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.braindev.2018.11.011","article-title":"Treatment options in pediatric super-refractory status epilepticus","volume":"41","author":"Arayakarnkul","year":"2019","journal-title":"Brain Dev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.04.012","article-title":"Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus","volume":"144","author":"Arya","year":"2018","journal-title":"Epilepsy Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.seizure.2018.02.003","article-title":"Febrile infection-related epilepsy syndrome (FIRES): therapeutic complications, long-term neurological and neuroimaging follow-up","volume":"56","author":"Lee","year":"2018","journal-title":"Seizure."},{"key":"B21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12028-016-0312-4","article-title":"A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus","volume":"26","author":"Farias-Moeller","year":"2017","journal-title":"Neurocrit Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2016.07.006","article-title":"Ketogenic diet treatment for pediatric super-refractory status epilepticus","volume":"41","author":"Appavu","year":"2016","journal-title":"Seizure."},{"key":"B23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ejpn.2016.08.004","article-title":"From intravenous to enteral ketogenic diet in PICU: a potential treatment strategy for refractory status epilepticus","volume":"20","author":"Chiusolo","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1684\/epd.2016.0849","article-title":"Electroclinical phenotypes and outcomes in TBC1D24-related epilepsy","volume":"18","author":"Appavu","year":"2016","journal-title":"Epileptic Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1684\/epd.2015.0781","article-title":"The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus","volume":"17","author":"Caraballo","year":"2015","journal-title":"Epileptic Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.pedneo.2015.01.010","article-title":"Ketogenic diet as a therapeutic option in super-refractory status epilepticus","volume":"56","author":"Fung","year":"2015","journal-title":"Pediatr Neonatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.pediatrneurol.2014.12.008","article-title":"Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient","volume":"52","author":"Lin","year":"2015","journal-title":"Pediatr Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.pediatrneurol.2015.01.009","article-title":"Protein-losing enteropathy as a rare complication of the ketogenic diet","volume":"52","author":"Moriyama","year":"2015","journal-title":"Pediatr Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/0883073813516192","article-title":"The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units","volume":"30","author":"Cobo","year":"2015","journal-title":"J Child Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.pediatrneurol.2014.03.016","article-title":"Re: the ketogenic diet for the treatment of pediatric status epilepticus","volume":"51","author":"Fung","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2013.07.020","article-title":"The ketogenic diet for the treatment of pediatric status epilepticus","volume":"50","author":"O'Connor","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1431","DOI":"10.1542\/peds.2013-3106","article-title":"Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet","volume":"134","author":"Singh","year":"2014","journal-title":"Pediatrics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejpn.2013.05.001","article-title":"Ketogenic diet in 3 cases of childhood refractory status epilepticus","volume":"17","author":"Sort","year":"2013","journal-title":"Eur J Paediatr Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.seizure.2013.04.005","article-title":"Febrile infection-related epilepsy syndrome: a study of 12 patients","volume":"22","author":"Caraballo","year":"2013","journal-title":"Seizure."},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.33588\/rn.5501.2011700","article-title":"[Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics]","volume":"55","author":"Vaccarezza","year":"2012","journal-title":"Rev Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1111\/j.1528-1167.2011.03293.x","article-title":"AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities?","volume":"52","author":"Ismail","year":"2011","journal-title":"Epilepsia."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/j.1528-1167.2010.02703.x","article-title":"Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES)","volume":"51","author":"Nabbout","year":"2010","journal-title":"Epilepsia."},{"key":"B39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1469-8749.2008.03216.x","article-title":"The ketogenic diet improves recently worsened focal epilepsy","volume":"51","author":"Villeneuve","year":"2009","journal-title":"Dev Med Child Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1684\/epi.2010.0344","article-title":"[Febrile acute epileptic encephalopathies in children]","volume":"22","author":"Nabbout","year":"2010","journal-title":"Epilepsies."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.clnu.2017.11.001","article-title":"10 patients, 10 years - Long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: a prospective, multicenter case series","volume":"37","author":"Heussinger","year":"2018","journal-title":"Clin Nutr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/nu9050517","article-title":"Effects of ketogenic diets on cardiovascular risk factors: evidence from animal and human studies","volume":"9","author":"Kosinski","year":"2017","journal-title":"Nutrients."},{"key":"B43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-017-0053-2","article-title":"Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies","volume":"13","author":"Cai","year":"2017","journal-title":"World J Pediatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2004-820992","article-title":"Fatal propofol infusion syndrome in association with ketogenic diet","volume":"35","author":"Baumeister","year":"2004","journal-title":"Neuropediatrics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","article-title":"Timing in the treatment of status epilepticus: from basics to the clinic","volume":"68","year":"2019","journal-title":"Seizure."},{"key":"B46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.seizure.2020.07.003","article-title":"Ketogenic diet treatment of children in the intensive care unit: safety, tolerability, and effectiveness","volume":"80","author":"Worden","year":"2020","journal-title":"Seizure."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.643105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T06:13:43Z","timestamp":1615529623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.643105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":46,"alternative-id":["10.3389\/fneur.2021.643105"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.643105","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"article-number":"643105"}}